Core Viewpoint - The company emphasizes enhancing operational performance and intrinsic value as the foundation of its market value management, aiming to balance company value and market capitalization to provide better returns to shareholders [1] Group 1 - The company actively communicates its value through various channels, including information disclosure and investor relations management [1] - The company is committed to fulfilling its information disclosure obligations in accordance with relevant regulations if there are any related plans [1]

Core Viewpoint - The company Furuida (600223) has achieved recognition for its research on royal jelly acid, winning the 2025 GCC Annual Anti-Aging Technology Award [1] Group 1 - The company announced the launch of its Aier Doctor Jingyan Jinzhih series products, which are developed based on royal jelly acid [1] - The company plans to continue enhancing its brand's research capabilities and solidifying its technological leadership in royal jelly acid [1]

Core Viewpoint - The company Furuida (600223) emphasizes its commitment to consumer needs and strong research capabilities in developing high-quality domestic cosmetics, particularly highlighting its product "Aier Doctor Flash Charge Lotion" which focuses on anti-aging properties [1] Group 1: Product Features - The "Aier Doctor Flash Charge Lotion" is designed with a focus on "flash charge" anti-aging, incorporating brown algae extract to regulate skin micro-ecology and inhibit aging bacteria [1] Group 2: Company Strategy - The company continues to prioritize consumer demand as a guiding principle in its product development [1] - Furuida aims to create cosmetics that instill national pride among consumers [1]

Core Viewpoint - The company Furida (600223) is actively expanding its cosmetics segment through a combination of online and offline channels to cover the national market [1] Group 1: Online Strategy - The company has established multiple flagship stores on major online platforms such as Tmall, Taobao, JD.com, and Douyin [1] Group 2: Offline Strategy - The company has implemented offline strategies by partnering with retailers like Sanfu Fashion, Mengke, and Watsons, achieving a presence in Hainan and Xiamen with over 50 stores [1] - Additionally, the brand Aier Doctor has also set up single-brand stores in these two regions [1]

Core Viewpoint - The company aims to enhance performance and ensure long-term shareholder returns by improving business quality and efficiency in response to short-term revenue pressures in the cosmetics and pharmaceutical sectors [1]. Group 1: Cosmetics Sector - The cosmetics segment will focus on differentiated brand development, leveraging the growth momentum of the Yilian spray product line while strengthening its advantages through brand culture promotion and targeted marketing [1]. - The company plans to accelerate the adjustment of the Aier Doctor brand, optimizing product lines by launching the upgraded 287 product line and an anti-aging series, alongside implementing comprehensive price control and content innovation to drive traffic conversion [1]. - New brands like Kemi will be rapidly scaled up to fill the growth gap [1]. Group 2: Pharmaceutical Sector - The pharmaceutical segment is seizing opportunities in the food and drug integration market, accelerating market penetration of seven new products based on industry standards it has led in formulating [1]. - The company is increasing its investment in research and development to promote both short-term performance improvement and long-term sustainable growth [1].

Core Viewpoint - The company is accelerating its brand internationalization efforts, focusing on its main brands, Yilian and Aier Doctor, and has already exported to countries such as the United States and Malaysia [1] Group 1 - The company is leveraging global platforms like the China International Import Expo to enhance its overseas market presence [1] - The company aims to connect with international brand export resources to create a model for overseas markets [1] - The goal is to provide global consumers with more high-quality skincare products [1]

证券日报网讯 福瑞达11月26日在互动平台回答投资者提问时表示，公司坚信市值管理的核心在于以稳 健经营为根本，以合规信息披露为底线，最终实现与投资者的共赢，推动市值与业绩长期协同。若后续 有相关计划且达到信息披露标准，公司将严格依照监管要求履行披露义务。 （编辑 楚丽君） ...

福瑞达（600223.SH）11月26日在投资者互动平台表示，公司旗下山东明仁福瑞达制药股份有限公司拥 有多款感冒系列的中成药，其具体应用需结合专业人士指导建议。 （记者 张明双） 每经AI快讯，有投资者在投资者互动平台提问：董秘你好，公司有治疗流感的产品吗？ ...

Core Viewpoint - The company, Furuida (600223.SH), is actively expanding its cosmetic sales through both online and offline channels across the national market, including specific efforts in Hainan and Xiamen [1] Group 1: Online Sales Strategy - The company has established multiple flagship stores on major online platforms such as Tmall, Taobao, JD.com, and Douyin [1] Group 2: Offline Sales Strategy - The company has a physical presence in Hainan and Xiamen through partnerships with retailers like Sanfu Fashion, Mengke, and Watsons, with over 50 stores opened in these regions [1] - Additionally, the brand "Aier Doctor" has also set up single-brand stores in both locations [1]

Core Viewpoint - The company has officially launched its anti-aging product, Wangjiangsu Acid, which has received a significant domestic award, indicating a strong market entry and potential for growth in the anti-aging sector [1] Group 1: Product Development - The company has developed a series of products based on Wangjiangsu Acid, named Aier Doctor's Refined Golden Series, which has now been officially launched [1] - The company is planning to expand into overseas markets based on its overall development strategy and market demand [1]